The total arbutin content in the leaves of all the studied Bergenia plants (B. crassifolia, B. ciliata and B. x ornata) was determined. The highest values of the arbutin content have been established for B. crassifolia (58.9 ± 0.7 mg.g -1 DW) and B. x ornata (51.0 ± 1.21 mg.g -1 DW), and the lowest for B. ciliata (5.9 ± 0.6 mg.g -1 DW). Arbutin concentration in the Bergenia leaves was the lowest in spring, in the autumn, on the contrary it increased. All the tested aqueous extracts caused a dose-dependent increase in diphenolase activity of fungal tyrosinase in a similar way as arbutin. On the other hand, all the ethanol extracts inhibited the diphenolase activity of tyrosinase.
Bergenia species contain various therapeutically important compounds in their flowers, leaves, roots and stems. Until now, from rhizomes and leaves of Bergenia plants there were isolated and identified more than 100 different compounds [1] . Polyphenols, flavonoids and quinones are the main bioactive compounds occurring in Bergenia genus. Bergenia plants contain bioactive ingredients primarily in their rhizomes. Rhizomes are thus, for example, the main source of phenolic compounds: arbutin, bergenin and afzelechin [2] . The seeds contain bergenin, coumarins, tannins, gallic acid, minerals and waxes.
The leaves and rhizomes of Bergenia plants are a major source of phenolic glycoside-arbutin (4-hydroxyphenyl-β-D-glucopyranoside). Arbutin was isolated from the fresh leaves of the B. crassifolia for the first time in the year 1930 [3] . Free arbutin aglycon hydroquinone occurs only in the footsteps in the fresh plant. B. crassifolia is in the literature referred to as one of the richest natural arbutin resources (rhizomes: 17 -23 %, leaves about 7.5 %) [4, 5] . In the leaves of B. crassifolia three galloyl esters of arbutin: 2-O-caffeoylarbutin, 6-O-galloylarbutin and p-galloyloxyphenyl β-D-glucoside were there also identified [4, 6, 7] .
Arbutin in higher quantities occurs also in the leaves of Arctostaphyllos uva-ursi L. [8] or in smaller levels in Vaccinium vitis-idae L., Pyrus communis L. and Lathyrus sp. [4] . Arbutin is a derivative of hydroquinone (hydroquinone-O-β-D-glucopyranoside) and is used as an effective treatment of hyperpigmentary disorders. It inhibits production of the skin pigment melanin by competitively and reversibly binding tyrosinase, a key enzyme in the process of melanogenesis [9, 10] . Tyrosinase is a copper-containing enzyme, which catalyses 2 initial steps in the formation of pigment melanin: hydroxylation of tyrosine and the oxidation of 3,4-dihydroxyphenylalanine [11] . Hydroquinone generated from arbutin by the action of β-glucosidase is the main active molecule. Hydroquinone itself is also used as a whitening agent. However, because of its side effects such as permanent depigmentation, exogenous ochronosis following long-term use and cancer risk concerns hydroquinone has been banned in many countries including EU [12, 13, 14] . Arbutin displays less melanocyte cytotoxicity than hydroquinone [14] and is used in various whitening cosmetic products as a safe alternative to commonly used depigmenting agents.
Another therapeutic use of arbutin is in the treatment of the genitourinary tract infections. Hydroquinone and methylarbutin as arbutin metabolites are responsible for these antibacterial effects [15] .
In this study we determined the arbutin content in the leaves of Bergenia crassifolia L. (Fritsch.), Bergenia ciliata (Haw.) Sternb and Bergenia x ornata Stein. collected in spring or autumn within three years. Representative samples were then diluted in water or 60% ethanol and tested for their ability to modulate tyrosinase diphenolase activity.
The total arbutin content in the leaves of all the studied Bergenia plants (B. crassifolia, B. ciliata and B. x ornata) was determined according to the methodology listed in the Czech Pharmacopoeia 2009. Arbutin levels in the dry matter were in the range from 24.6 (± 1.1) to 58.9 (± 0.7) mg.g -1 for B. crassifolia; from 34.2 (± 0.9) to 51.0 (± 1.2) mg.g -1 for B. x ornata and between 5.9 (± 0.6) to 9.4 (± 0.6) mg.g -1 for B. ciliata ( Table 1 ). The highest values of the arbutin content have been established for B. crassifolia (58.9 ± 0.7 mg.g -1 ) and B. x ornata (51.0 ± 1.2 mg.g -1 ), and the lowest for B. ciliata (5.9 ± 0.6 mg.g -1 [16] . Jiang et al. [17] indicates the arbutin content in the leaves of B. purpurascens in the range from 15.1 -63.6 mg.g -1 DW.
The obtained results showed that the arbutin level ranged from spring to autumn. Arbutin concentration in Bergenia leaves was the lowest in spring, in the autumn, on the contrary it increased. This tendency was observed in sample BCR 1, which was taken always from one of the plants in the course of the years 2011 to 2013 (similar to the sample of the BORON 1 and BCL 1). Arbutin content in the DW of leaves collected in the autumn was 32.4 (± 0.1) mg.g -1 (year 2011) and 41.7 (± 1.0) mg.g -1 (2012), the spring 31.9 (± 0.9) mg.g-1 (2012) and 25.1 (± 1.0) mg.g -1 (2013) ( Table 1) .
As is apparent from the literature, a similar pattern of arbutin variation in the course of the year was observed not only in B. crassifolia [4] but in Arctostaphyllos uva-ursi [18] . A higher content of arbutin recorded in autumn, may be affected by the climatic conditions. The arbutin content can additionally be affected NPC Natural Product Communications 2017 Vol. 12 No. 4 549 -552 by the age of the plants. As stated Lubsandorzhieva et al. [16, 19, 20] , the arbutin level is the highest in the annual sheets, with the ageing of plants is gradually decreasing. The effect of drying temperature (40°C, 50°C) on the arbutin content was also monitored. A significant difference in the resulting values here, however, has not been shown.
On the basis of the proven arbutin content in the leaves of B. crassifolia, B. ciliata and B. x ornata the modulation of fungal tyrosinase diphenolase activity was performed. For this purpose the aqueous and 60% ethanol Bergenia extracts from the samples BCR 3 from B. crassifolia both green and red leaves, BCL 1 from B. ciliata green leaves and BOR 1 from B. x ornata green leaves all from autumn collection 2012 were used. Kojic acid and arbutin as well-established tyrosinase modulators were used as standards [21, 22] . Kojic acid is a typical tyrosinase inhibitor whereas arbutin has a dual effect on fungal tyrosinase activity]. In this study we assessed the diphenolase activity of tyrosinase using L-DOPA as a substrate therefore we observed its activation by arbutin in contrast to kojic acid which had the opposite effect (Figures 1, 2 ).
All the tested aqueous extracts caused a dose-dependent increase in diphenolase activity of fungal tyrosinase in a similar way as arbutin ( Fig. 1) . No significant differences between red and green leaf extracts of B. crassifolia nor between extracts from different species were observed. On the other hand, all the ethanol extracts inhibited the tyrosinase diphenolase activity probably due to the low content of arbutin and higher levels of other, more hydrophobic active compounds such as quercetin present in these plants (Figure 2 ). Similar inhibitory effect was observed with kojic acid as a standard tyrosinase inhibitor. When we compared the effect of the extract from red and green leaves of B. crassifolia, statistically significant differences were observed only in the concentrations 63 and 125 µg/mL, but higher concentration had a comparable effect again.
There are several other compounds present in extracts from Bergenia plants with tyrosinase modulating properties. These include quercetin [21, 23] which has already been shown to inhibit the fungal tyrosinase activity using L-DOPA as a substrate [24, 25] . Due to the fact that arbutin possesses tyrosinase diphenolase activating properties whereas quercetin inhibits this enzyme, we can easily distinguish between extracts containing arbutin as the major tyrosinase-modulating compound and extracts with low arbutin content and higher concentrations of other typical tyrosinase inhibitors present in Bergenia plants. Because arbutin is a watersoluble compound we expected it to be the major tyrosinasemodulating substance in the aqueous extracts. Indeed, all the aqueous extracts exhibited similar tyrosinase-activating properties as pure arbutin. However, no statistically significant correlation between the arbutin content and tyrosinase activity was observed.
The inhibition of tyrosinase activity by ethanol extracts on the other hand confirms low content of arbutin which is not well soluble in 60% ethanol. These inhibitory effects are probably caused by more hydrophobic compounds soluble in ethanol, which have previously been shown to be present in Bergenia plants and to possess tyrosinase inhibitory properties such as quercetin for instance.
The highest decrease in fungal tyrosinase activity caused the most concentrated ethanol extract of B. x ornata (250 µg.ml -1 ; 0.7 ± 0.1)
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Natural Product Communications Vol. 12 (4) 2017 551 %). Ethanol extract of B.ciliata also reached significant tyrosinase inhibition. Tyrosinase activity gradually decreased with the increasing concentrations of the extracts. Ethanol extracts of B. ciliata, B. crassifolia, B. x ornata showed a very similar ability to inhibit the tyrosinase. When comparing the inhibition of the tyrosinase enzyme for the red and green leaves of B. crassifolia statistically significant difference (green leaves -0.7 (± 0.1) %; red leaves -of 0.8 (± 0.1) % was not demonstrated. Results showed that the higher inhibition of tyrosinase activity the ethanol extracts have reached. The aqueous Bergenia extracts on the contrary tyrosinase activity did not show.
As is apparent from the literature, a similar inhibition as arbutin has also hydroquinone and quercetin, the substances also present in the leaf extracts of Bergenia plants [21, 23] . Although arbutin is water soluble, hydroquinone and quercetin are substances in the water, unlike ethanol, almost insoluble. It may be the reason why higher inhibition activities of the tyrosinase ethanol extracts have reached in comparison with aqueous, where this ability is demonstrated. A statistical dependence between the observed values of the arbutin content and inhibiting tyrosinase activity also has not been demonstrated. It also suggests that other chemical compounds have on the conscience the decrease of tyrosinase activity.
Tyrosinase (monophenol monooxygenase) uses molecular oxygen for the hydroxylation of L-tyrosine on the o-diphenol-3,4phenylalanine (DOPA) and the oxidation of DOPA to dopaquinone, which is a precursor of eumelanine and pheomelanine. Dopaquinone is spontaneously converted to leucodopachrome, subsequently, on the dopachrome and after a series of oxidationreduction reactions on the monomeric precursor 5,6dihydroxyindole (DHI) and DHI-2-carboxylic acid (DHICA). In the case when dopachrome is not subject to spontaneous decarboxylation on the DHI, it is enzymatically converted to DHICA, which is then oxidized through the TRP 1. DHICA and DHI subsequently polymerize and form eumelanine [26] .
The study of Tada et al. [27] revealed that in the course of the catalytic conversion of L-tyrosine on dopaquinone the hydroxyl radicals are produced. Tyrosinase inhibitors so can influence the oxidative changes in the skin by inhibition of these radicals. Qin et al. [21] showed the different arbutin activity against monophenol monooxygenase and diphenol monooxygenase, which catalyzes the oxygenation of monophenol (tyrosine) on diphenols and further oxidation of the diphenols (L-DOPA) to quinones (dopaquinone). Arbutin inhibited the enzymatic activity of monophenoloxygenase, however, it increased the diphenolase activity. In addition, it has anti-inflammatory effects and relieves skin inflammation caused by exposure of the skin to UV radiation [28] . The ability of arbutin to inhibit melanogenesis proved with the help of the ex vivo tissue cultures of skin cells Lim et al. [28] .
Experimental
Plant materials: Leaves of Bergenia crassifolia L. (Fritsch.), Bergenia cilliata Sternb. and Bergenia x ornata were obtained from the Botanical Garden of Faculty of Horticulture, Mendel University in Brno.
Methods:
To determine the arbutin content 130 Bergenia plants of the spring (May) and autumn (September) collections from the years 2011 to 2013 were included. Four substantively statistically significant samples of them were then selected and have been included in evaluation of tyrosinase activity.
Arbutin content:
The total arbutin content in green and red leaves of B. crassifolia, B. ciliata and B. x ornata was determined according to the pharmacopoeia methodology for the determination of the arbutin content for drug Uvae ursi folium listed in the Czech Pharmacopoeia 2009 [29] .
Tyrosinase activity:
The diphenolase activity of fungal tyrosinase (2138 U.ml -1 , Sigma) was measured spectrophotometrically using L-DOPA (Sigma) as a substrate according to Jimenez et al. [30] , with slight modifications. The aqueous and ethanol extracts from the samples BCR 3 from B. crassifolia both green and red leaves, BCL 1 from B. ciliata green leaves and BOR from B. x ornata green leaves all from autumn collection 2012 were mixed with 1 mg.ml -1 L-DOPA, 500 U.ml -1 fungal tyrosinase in phosphate buffered saline (pH 7.4) and incubated at 37 °C for 1 hour. The dopachrome formation was monitored at 405 nm using a Versa Max ELISA Microplate Reader (Molecular Devices). Kojic acid and arbutin as well-established tyrosinase modulators were used as standards [21, 22] .
